A highly active S1-P1 nuclease from the opportunistic pathogen Stenotrophomonas maltophilia cleaves c-di-GMP

FEBS Lett. 2023 Aug;597(16):2103-2118. doi: 10.1002/1873-3468.14683. Epub 2023 Jun 19.

Abstract

A number of multidrug-resistant bacterial pathogens code for S1-P1 nucleases with a poorly understood role. We have characterized a recombinant form of S1-P1 nuclease from Stenotrophomonas maltophilia, an opportunistic pathogen. S. maltophilia nuclease 1 (SmNuc1) acts predominantly as an RNase and is active in a wide range of temperatures and pH. It retains a notable level of activity towards RNA and ssDNA at pH 5 and 9 and about 10% of activity towards RNA at 10 °C. SmNuc1 with very high catalytic rates outperforms S1 nuclease from Aspergillus oryzae and other similar nucleases on all types of substrates. SmNuc1 degrades second messenger c-di-GMP, which has potential implications for its role in the pathogenicity of S. maltophilia.

Keywords: S1-P1 nuclease; Stenotrophomonas maltophilia; c-di-GMP; cyclic diguanylate; nosocomial infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclic GMP / metabolism
  • Endonucleases / metabolism
  • RNA / metabolism
  • Stenotrophomonas maltophilia* / genetics
  • Stenotrophomonas maltophilia* / metabolism

Substances

  • bis(3',5')-cyclic diguanylic acid
  • Cyclic GMP
  • Endonucleases
  • RNA